Min Lu

Company: Eli Lilly & Co.

Job title: Executive Director

Seminars:

Rewiring Vascular Remodeling Pathways in Pulmonary Hypertension & Fibrotic Vascular Disease 9:00 am

Explore the role of integrins and key proliferative signalling pathways in driving vascular remodelling and smooth muscle hyperplasia in pulmonary hypertension Highlight emerging preclinical insights from transcriptomic and in vivo studies identifying actionable targets for reversing vascular stiffness and dysfunction Assess how vascular-targeted antifibrotic approaches could translate to broader fibrotic conditions involving vascular remodelling, including…Read more

day: Conference Day One